177 related articles for article (PubMed ID: 9602252)
1. Congenital toxoplasmosis: efficacy of maternal treatment with spiramycin alone.
Vergani P; Ghidini A; Ceruti P; Strobelt N; Spelta A; Zapparoli B; Rescaldani R
Am J Reprod Immunol; 1998 May; 39(5):335-40. PubMed ID: 9602252
[TBL] [Abstract][Full Text] [Related]
2. Spiramycin/cotrimoxazole versus pyrimethamine/sulfonamide and spiramycin alone for the treatment of toxoplasmosis in pregnancy.
Valentini P; Buonsenso D; Barone G; Serranti D; Calzedda R; Ceccarelli M; Speziale D; Ricci R; Masini L
J Perinatol; 2015 Feb; 35(2):90-4. PubMed ID: 25211284
[TBL] [Abstract][Full Text] [Related]
3. Prenatal therapy with pyrimethamine + sulfadiazine vs spiramycin to reduce placental transmission of toxoplasmosis: a multicenter, randomized trial.
Mandelbrot L; Kieffer F; Sitta R; Laurichesse-Delmas H; Winer N; Mesnard L; Berrebi A; Le Bouar G; Bory JP; Cordier AG; Ville Y; Perrotin F; Jouannic JM; Biquard F; d'Ercole C; Houfflin-Debarge V; Villena I; Thiébaut R;
Am J Obstet Gynecol; 2018 Oct; 219(4):386.e1-386.e9. PubMed ID: 29870736
[TBL] [Abstract][Full Text] [Related]
4. Is sulfadiazine alone equivalent (benefit and harm) to spiramycin to treat acute toxoplasmosis in the first trimester of pregnancy?
Bernardo WM; Chinzon M; Chaves FG
Rev Assoc Med Bras (1992); 2015; 61(6):495-6. PubMed ID: 26841157
[No Abstract] [Full Text] [Related]
5. [Diagnosis and therapy of toxoplasmosis infections in pregnancy at the Rostock University Gynecologic Clinic 1986-1994].
Briese V; Rogmann K; Müller H; Plesse R
Zentralbl Gynakol; 1995; 117(11):578-84. PubMed ID: 8533491
[TBL] [Abstract][Full Text] [Related]
6. [Congenital toxoplasmosis: prevention in the pregnant woman and management of the neonate].
Pelloux H; Fricker-Hidalgo H; Pons JC; Bost-Bru C; Brenier-Pinchart MP; Jouk PS; Ambroise-Thomas P
Arch Pediatr; 2002 Feb; 9(2):206-12. PubMed ID: 11915504
[TBL] [Abstract][Full Text] [Related]
7. Assessment of laboratory methods used in the diagnosis of congenital toxoplasmosis after maternal treatment with spiramycin in pregnancy.
Rodrigues IM; Costa TL; Avelar JB; Amaral WN; Castro AM; Avelino MM
BMC Infect Dis; 2014 Jun; 14():349. PubMed ID: 24961630
[TBL] [Abstract][Full Text] [Related]
8. Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year.
Foulon W; Villena I; Stray-Pedersen B; Decoster A; Lappalainen M; Pinon JM; Jenum PA; Hedman K; Naessens A
Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):410-5. PubMed ID: 9988811
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic problems and postnatal follow-up in congenital toxoplasmosis.
Mazzola A; Casuccio A; Romano A; Schimmenti MG; Titone L; Di Carlo P
Minerva Pediatr; 2007 Jun; 59(3):207-13. PubMed ID: 17519865
[TBL] [Abstract][Full Text] [Related]
10. Congenital toxoplasmosis and prenatal care state programs.
Avelino MM; Amaral WN; Rodrigues IM; Rassi AR; Gomes MB; Costa TL; Castro AM
BMC Infect Dis; 2014 Jan; 14():33. PubMed ID: 24438336
[TBL] [Abstract][Full Text] [Related]
11. Treatment of congenital toxoplasmosis during pregnancy.
Wilson CB
J Pediatr; 1990 Jun; 116(6):1003-5. PubMed ID: 2348287
[No Abstract] [Full Text] [Related]
12. Treatment of toxoplasmosis in pregnancy: concentrations of spiramycin and neospiramycin in maternal serum and amniotic fluid.
Gratzl R; Sodeck G; Platzer P; Jäger W; Graf J; Pollak A; Thalhammer T
Eur J Clin Microbiol Infect Dis; 2002 Jan; 21(1):12-6. PubMed ID: 11913495
[TBL] [Abstract][Full Text] [Related]
13. Role of spiramycin in prevention of fetal toxoplasmosis.
Avci ME; Arslan F; Çiftçi Ş; Ekiz A; Tüten A; Yildirim G; Madazli R
J Matern Fetal Neonatal Med; 2016; 29(13):2073-6. PubMed ID: 26365472
[TBL] [Abstract][Full Text] [Related]
14. Congenital toxoplasmosis.
Olliaro P
Clin Evid; 2002 Jun; (7):623-6. PubMed ID: 12230689
[No Abstract] [Full Text] [Related]
15. Toxoplasmosis in pregnancy.
Wong SY; Remington JS
Clin Infect Dis; 1994 Jun; 18(6):853-61; quiz 862. PubMed ID: 8086543
[No Abstract] [Full Text] [Related]
16. Successful tolerance induction to spiramycin in pregnancy.
Nucera E; Roncallo C; Masini L; Buonomo A; De Pasquale T; Pollastrini E; Schiavino D; Patriarca G
Scand J Infect Dis; 2002; 34(7):550-1. PubMed ID: 12195890
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis and treatment of congenital toxoplasmosis].
Koskiniemi M
Duodecim; 1993; 109(14):1260-4. PubMed ID: 8062703
[No Abstract] [Full Text] [Related]
18. Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment.
Hohlfeld P; Daffos F; Thulliez P; Aufrant C; Couvreur J; MacAleese J; Descombey D; Forestier F
J Pediatr; 1989 Nov; 115(5 Pt 1):765-9. PubMed ID: 2681638
[TBL] [Abstract][Full Text] [Related]
19. [Management of congenital toxoplasmosis in France: current data].
Garcia-Méric P; Franck J; Dumon H; Piarroux R
Presse Med; 2010 May; 39(5):530-8. PubMed ID: 19926248
[TBL] [Abstract][Full Text] [Related]
20. Management of toxoplasmosis.
Georgiev VS
Drugs; 1994 Aug; 48(2):179-88. PubMed ID: 7527323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
